Rachel Jia

423 total citations
16 papers, 256 citations indexed

About

Rachel Jia is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rachel Jia has authored 16 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rachel Jia's work include Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Rachel Jia is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Rachel Jia collaborates with scholars based in United States, Sweden and Italy. Rachel Jia's co-authors include Matthew D. Galsky, Reza Mehrazin, John P. Sfakianos, Nikhil Waingankar, Kathryn E. Marqueen, Madhu Mazumdar, Bart S. Ferket, Vishal Gupta, Richard L. Bakst and Peter M. Som and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Rachel Jia

16 papers receiving 250 citations

Peers

Countries citing papers authored by Rachel Jia

Since Specialization

Citations

This map shows the geographic impact of Rachel Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Jia more than expected).

Fields of papers citing papers by Rachel Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Jia. The network helps show where Rachel Jia may publish in the future.

Co-authorship network of co-authors of Rachel Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Jia. A scholar is included among the top collaborators of Rachel Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Jia. Rachel Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Survival and Quality of Life Analysis in a Randomized Deintensification Trial for Locally Advanced HPV Positive Oropharynx Cancer Patients 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Marshall R. Posner, (unknown), (unknown), Vishal Gupta, Brett A. Miles, Richard L. Bakst, Eric M. Genden, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachel Jia, Erin Moshier, Peter M. Som, Marcelo Bonomi	2
2	Risk factors for heterotopic ossification in operatively treated proximal humeral fractures 2020 ·The Bone & Joint Journal ·(unknown), Jimmy J. Chan, Diana C. Patterson, Rachel Jia, Jashvant Poeran, Bradford O. Parsons, Paul J. Cagle	13
3	Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer 2019 ·Cancer ·Alberto Martini, Rachel Jia, Bart S. Ferket, Nikhil Waingankar, Elizabeth R. Plimack, Simon J. Crabb, Lauren C. Harshman, Evan Y. Yu, Thomas Powles, Jonathan E. Rosenberg, Sumanta K. Pal, Ulka N. Vaishampayan, Andrea Necchi, Peter Wiklund, Reza Mehrazin, Madhu Mazumdar, John P. Sfakianos, Matthew D. Galsky	26
4	The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer 2019 ·Urologic Oncology Seminars and Original Investigations ·Nikhil Waingankar, Rachel Jia, Kathryn E. Marqueen, François Audenet, John P. Sfakianos, Reza Mehrazin, Bart S. Ferket, Madhu Mazumdar, Matthew D. Galsky	18
5	Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis 2019 ·European Urology ·Scot A. Niglio, Rachel Jia, Jiayi Ji, (unknown), Vaibhav G. Patel, Alberto Martini, John P. Sfakianos, Kathryn E. Marqueen, Nikhil Waingankar, Reza Mehrazin, Peter Wiklund, William Oh, Madhu Mazumdar, Bart S. Ferket, Matthew D. Galsky	36
6	Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial 2019 ·Oral Oncology ·(unknown), Vishal Gupta, Brett A. Miles, Richard L. Bakst, Eric M. Genden, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachel Jia, Erin Moshier, (unknown), (unknown), Peter M. Som, Marshall R. Posner	76
7	SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy 2019 ·Journal of the Endocrine Society ·Amanda Leiter, Rachel Jia, Emily Carroll, (unknown), (unknown), (unknown), Matthew D. Galsky, Emily J. Gallagher	1
8	“Lipase Only, Please”: Reducing Unnecessary Amylase Testing 2019 ·The Joint Commission Journal on Quality and Patient Safety ·(unknown), (unknown), Kathryn E. Marqueen, (unknown), Anthony Yang, Andrew Dunn, Rachel Jia, Jashvant Poeran, Hyung J. Cho	6
9	Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States 2018 ·JNCI Cancer Spectrum ·Kathryn E. Marqueen, Nikhil Waingankar, John P. Sfakianos, Reza Mehrazin, Scot A. Niglio, François Audenet, Rachel Jia, Madhu Mazumdar, Bart S. Ferket, Matthew D. Galsky	14
10	Identifying high surgical risk in muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC). 2018 ·Journal of Clinical Oncology ·Kathryn E. Marqueen, Nikhil Waingankar, John P. Sfakianos, Reza Mehrazin, Scot A. Niglio, François Audenet, Rachel Jia, Madhu Mazumdar, Bart S. Ferket, Matt D. Galsky	2
11	Telemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate Cancer 2017 ·JCO Clinical Cancer Informatics ·Matthew D. Galsky, (unknown), Rachel Jia, David R. Shaffer, (unknown), Che‐Kai Tsao, Charles Baker, Amanda Leiter, John J. Holland, Tomasz Sablinski, Reza Mehrazin, John P. Sfakianos, (unknown), William Oh	22
12	Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients. 2017 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Krzysztof Misiukiewicz, Vishal Gupta, Richard L. Bakst, David Y. Zhang, Tamar Kotz, Peter M. Som, Karen S. Anderson, Brett A. Miles, (unknown), Marita S. Teng, Marcelo Bonomi, Andrew G. Sikora, Elizabeth G. Demicco, Rachel Jia, Marshall R. Posner	9
13	Comparative Patient-Centered Outcomes (Health State and Adverse Sexual Symptoms) Between Adjuvant Brachytherapy Versus No Adjuvant Brachytherapy in Early Stage Endometrial Cancer 2014 ·Annals of Surgical Oncology ·Shari Damast, Kaled M. Alektiar, Anne Eaton, Naamit K. Gerber, Shari Goldfarb, Sujata Patil, Rachel Jia, Mario M. Leitão, Jeanne Carter, Ethan Basch	19
14	Comparison of Automated Platelet Counts and Potential Effect on Transfusion Decisions in Cancer Patients 2013 ·American Journal of Clinical Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachel Jia, (unknown), (unknown), (unknown), P. Maslak	10
15	PD04-03: Sexual Dysfunction in Premenopausal Women with Breast Cancer: Prevalence and Severity. 2011 ·Cancer Research ·(unknown), Maura N. Dickler, Sujata Patil, Rachel Jia, Laura Sit, Shari Damast, (unknown), Jennifer B. Kaplan, Clifford A. Hudis, Ethan Basch	1
16	Burden of Sexual Dysfunction in Women with Breast Cancer. 2009 ·Cancer Research ·(unknown), Maura N. Dickler, M. Fruscione, Laura Sit, Rachel Jia, Jennifer B. Kaplan, (unknown), Thomas M. Atkinson, Clifford A. Hudis, Ethan Basch	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact